An intravenous therapy system may include a hollow needle comprising a distal end and a proximal end, the distal end comprising a sharp tip for insertion into a vein; an infrared (IR) camera placed within a hollow portion of the hollow needle, including: an IR detector; a first light source to emit a first wavelength of IR light; and a second light source to emit a second wavelength of IR light; a comparator to, upon execution of a processor communicatively coupled to the comparator, compare an amount of reflected light received at the IR detector during activation of the first light and second light and provide an indication of light absorption within a vein.

The disclosed embodiments relate to multimodal imaging system comprising a fiber-coupled fluorescence imaging system, which operates based on ultra-violet (UV) excitation light, and a fiber-coupled optical coherence tomography (OCT) imaging system. The multimodal imaging system also includes a fiber optic interface comprising a single optical fiber, which facilitates light delivery to a sample-of-interest and collection of returned optical signals for both the fluorescence imaging system and the OCT imaging system. During operation of the system, the single optical fiber carries both UV light and coherent infrared light through two concentric light-guiding regions, thereby facilitating generation of precisely co-registered optical data from the fluorescence imaging system and the OCT imaging system.

A breast cancer diagnosis system includes a probe that sequentially outputs light of a plurality of wavelengths of a near-infrared area to a target object, receives reflected light, and sequentially processes the reflected light; a central control device that receives optical data of the reflected light sensed by the probe, calculates a concentration of chromophore of the target object for each chromophore, and generates an image of the chromophores indicating a distribution of the concentration value of each chromophore; and a display that outputs the image, in which in the probe, one or more channel signal processing units including one or more light irradiation modules and light collection modules may be disposed, and each of the channel signal processing units sequentially operates so that each of the channel signal processing units may generate the optical data of the reflected light.

The present invention provides compositions and methods for imaging tumor resections.

Improved fluoresced imaging (FI) endoscope devices and systems are provided to enhance use of endoscopes with FI and visible light capabilities. An endoscope device is provided for endoscopy imaging in a white light and a fluoresced light mode. A chromatic adjustment assembly, typically implemented with prisms, compensates for a chromatic focal difference between the white light image and the fluoresced light image caused by the dispersive properties of the optical materials or optical design employed in the construction of the optical channel. The assembly is placed optically between the most proximal rod lens of the endoscope and the focusing optics, typically at an internal telecentric image space, to improve the chromatic correction. The prism assembly directs incoming light with different spectral content along separate paths which compensate for chromatic aberration.

Embodiments herein relate to devices and methods for assessing pulmonary congestion using optical sensing techniques. In an embodiment, a pulmonary congestion monitoring device can be included having a first optical emitter, wherein the first optical emitter can be configured to emit light at a first wavelength, such as at a near-infrared wavelength or an ultraviolet wavelength. The monitoring device can also include a first optical detector configured to detect incident light. The first optical emitter and the first optical detector can be separated by a distance of 1 centimeters (cm) to 10 cm. The monitoring device can be configured so that the light from the first optical emitter propagates through at least one of a lung tissue and an airway tissue. The monitoring device can also be configured to use detected incident light to determine a congestion status of the lung tissue. Other embodiments are also included herein.

An image processing device acquires an image obtained by irradiating an area of a living body with light having a wavelength of 955 [nm] to 2025 [nm]. The image processing device inputs the acquired image to a learned model or a statistical model generated in advance for detecting, from the image, a tumor present in the area, and determines whether or not a tumor is present at each point in the image.

An object is to provide an SWCNT slurry for bioimaging with reduced toxicity that causes no aggregation of semiconductor SWCNTs, no accumulation in a specific site when administered to a living organism, and no clogging in blood vessels such as those in the lungs. In order to achieve the above-described object, a semiconductor single-walled carbon nanotube (SWCNT) slurry for bioimaging according to the present invention includes: semiconductor SWCNTs having an average particle size of less than 10 nm; and a dispersant composed of an amphiphilic substance that coats the surfaces of the SWCNTs.

An example imaging apparatus that can operate at shortwave infrared (SWIR) wavelengths are provided. An example imaging apparatus may include a fiber optic bundle, a distal lens, an illumination assembly, and an imaging detector. The fiber optic bundle may comprise a plurality of fibers and may be configured to guide light energy at a SWIR wavelength. The distal lens may be disposed on a distal end of the fiber optic bundle and the distal lens configured to focus light energy at the SWIR wavelength. The illumination assembly may be configured to output illumination at the SWIR wavelength adjacent to the distal end of the fiber optic bundle toward an object. The imaging detector may be operably coupled to a proximal end of the fiber optic bundle and configured to receive imaging light energy at the SWIR wavelength reflected from the object and guided through the fiber optic bundle.

A system and method for manufacturing custom fit artificial nails includes a 3D surface scanning module and a 3D printing module and use thereof. A central processing module is connected to the 3D surface scanning module and the 3D printing module and performs: operating the 3D surface scanning module to obtain an image of a user's hands/feet; processing the image to create an input 3D model of nails of the user; generating an output 3D model corresponding to artificial nails matching dimensions of the user's nails according to the 3D input model; operating the 3D printing module to manufacture artificial nails according to the output 3D model; and generating medical data by correlating the identified features of the user's nails with known medical conditions, in order to diagnose a medical condition of the user which is known to exhibit the identified features as a symptom. Alternatively, or additionally, medicinal ingredient may be included in the artificial nail to treat the medical condition of the user. Embedded devices, sensors or an RFID chip may be integrated into the artificial nail.